Department of Biomedical Engineering, Rutgers -The State University of New Jersey, Piscataway, NJ, USA.
Department of Emergency Medicine, Resuscitation Engineering Science Unit, University of Washington School of Medicine, Seattle, WA, USA.
Thromb Res. 2022 Dec;220:131-140. doi: 10.1016/j.thromres.2022.10.017. Epub 2022 Oct 29.
Trauma induced coagulopathy (TIC) is common after severe trauma, increasing transfusion requirements and mortality among patients. TIC has several phenotypes, with primary hyperfibrinolysis being among the most lethal. We aimed to investigate the contribution of hypercoagulation, hemodilution, and fibrinolytic activation to the hyperfibrinolytic phenotype of TIC, by examining fibrin formation in a plasma-based model of TIC. We hypothesized that instabilities arising from TIC will be due primarily to increased fibrinolytic activation rather than hemodilution or tissue factor (TF) induced hypercoagulation.
The influence of TF, hemodilution, fibrinogen consumption, tissue plasminogen activator (tPA), and the antifibrinolytic tranexamic acid (TXA) on plasma clot formation and structure were examined using rheometry, optical properties, and confocal microscopy. These were then compared to plasma samples from trauma patients at risk of developing TIC.
Combining TF-induced clot formation, 15 % hemodilution, fibrinogen consumption, and tPA-induced fibrinolysis, the clot characteristics and hyperfibrinolysis were consistent with primary hyperfibrinolysis. TF primarily increased fibrin polymerization rates and reduced fiber length. Hemodilution decreased clot optical density but had no significant effect on mechanical clot stiffness. TPA addition induced primary clot lysis as observed mechanically and optically. TXA restored mechanical clot formation but did not restore clot structure to control levels. Patients at risk of TIC showed increased clot formation, and lysis like that of our simulated model.
This simulated TIC plasma model demonstrated that fibrinolytic activation is a primary driver of instability during TIC and that clot mechanics can be restored, but clot structure remains altered with TXA treatment.
创伤后凝血功能障碍(TIC)在严重创伤后很常见,会增加患者的输血需求和死亡率。TIC 有几种表型,其中原发性纤溶亢进症最为致命。我们旨在通过检查 TIC 血浆模型中的纤维蛋白形成,来研究高凝、血液稀释和纤维蛋白溶解激活对 TIC 高纤溶表型的贡献。我们假设 TIC 引起的不稳定性主要归因于纤维蛋白溶解激活的增加,而不是血液稀释或组织因子(TF)诱导的高凝。
使用流变学、光学特性和共聚焦显微镜检查 TF、血液稀释、纤维蛋白原消耗、组织型纤溶酶原激活物(tPA)和抗纤维蛋白溶解氨甲环酸(TXA)对血浆凝块形成和结构的影响。然后将这些结果与有发生 TIC 风险的创伤患者的血浆样本进行比较。
将 TF 诱导的凝块形成、15%的血液稀释、纤维蛋白原消耗和 tPA 诱导的纤溶作用相结合,凝块特征和高纤溶作用与原发性纤溶亢进一致。TF 主要增加纤维蛋白聚合速率并降低纤维长度。血液稀释降低了凝块的光密度,但对机械凝块刚度没有显著影响。tPA 的加入诱导了原发性凝块溶解,这在机械和光学上都可以观察到。TXA 恢复了机械凝块的形成,但没有将凝块结构恢复到对照水平。有 TIC 风险的患者表现出凝块形成增加和类似于我们模拟模型的溶解。
该模拟 TIC 血浆模型表明,纤维蛋白溶解激活是 TIC 期间不稳定性的主要驱动因素,尽管用 TXA 治疗可以恢复凝块力学特性,但凝块结构仍然保持改变。